Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Manolis

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
International Reviews of Immunology|November 21, 2018
Psoriasis and cardiovascular disease: the elusive linkAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Current Vascular Pharmacology|August 28, 2025
Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of HopeAntonis A Manolis, Theodora A Manolis, Apostolos Vouliotis, et al.
Vascular Health and Risk Management|January 11, 2020
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and PerspectivesAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Current Medicinal Chemistry|December 28, 2021
Gut Microbiota and Cardiovascular Disease: Symbiosis Versus DysbiosisAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Heart Failure Reviews|March 23, 2022
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive conditionAntonis S Manolis, Theodora A Manolis, Antonis A Manolis, et al.
Journal of Cardiovascular Electrophysiology|October 19, 2021
Electrocardiography of cardiac resynchronization therapy: Pitfalls and practical tipsAntonis S Manolis, Antonis A Manolis, Theodora A Manolis, et al.
European Journal of Internal Medicine|December 5, 2025
The neuro-cardiac axis in epilepsyTheodora A Manolis, Antonis A Manolis, Apostolos Vouliotis, et al.
Biomarker Insights|June 3, 2024
Are We Using Ezetimibe As Much As We Should?Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
Expert Opinion on Drug Safety|August 22, 2018
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
American Heart Journal|July 1, 1987
Pacemaker Wenckebach secondary to variable latency: an unusual form of hyperkalemic pacemaker exit blockP Varriale, A Manolis
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
International Reviews of Immunology|November 21, 2018
Psoriasis and cardiovascular disease: the elusive linkAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Current Vascular Pharmacology|August 28, 2025
Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of HopeAntonis A Manolis, Theodora A Manolis, Apostolos Vouliotis, et al.
Vascular Health and Risk Management|January 11, 2020
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and PerspectivesAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Current Medicinal Chemistry|December 28, 2021
Gut Microbiota and Cardiovascular Disease: Symbiosis Versus DysbiosisAntonis A Manolis, Theodora A Manolis, Helen Melita, et al.
Heart Failure Reviews|March 23, 2022
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive conditionAntonis S Manolis, Theodora A Manolis, Antonis A Manolis, et al.
Journal of Cardiovascular Electrophysiology|October 19, 2021
Electrocardiography of cardiac resynchronization therapy: Pitfalls and practical tipsAntonis S Manolis, Antonis A Manolis, Theodora A Manolis, et al.
European Journal of Internal Medicine|December 5, 2025
The neuro-cardiac axis in epilepsyTheodora A Manolis, Antonis A Manolis, Apostolos Vouliotis, et al.
Biomarker Insights|June 3, 2024
Are We Using Ezetimibe As Much As We Should?Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
Expert Opinion on Drug Safety|August 22, 2018
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
American Heart Journal|July 1, 1987
Pacemaker Wenckebach secondary to variable latency: an unusual form of hyperkalemic pacemaker exit blockP Varriale, A Manolis
Pageof 12